Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongfang Yu

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Neuroimmunology|May 28, 2025
Activation of NMDAR/Ca<sup>2+</sup>/CaKMII/ROS pathway by Brucella induced neuronal cell apoptosisMeiling Liu, Hongfang Yu, Yuzhe Wang, et al.
Pharmaceutics|June 27, 2024
Evaluation of Novel Nasal Mucoadhesive Nanoformulations Containing Lipid-Soluble EGCG for Long COVID TreatmentNicolette Frank, Douglas Dickinson, Garrison Lovett, et al.
Journal of Hazardous Materials|June 11, 2024
Using artificial intelligence to rapidly identify microplastics pollution and predict microplastics environmental behaviorsBinbin Hu, Yaodan Dai, Hai Zhou, et al.
Heliyon|March 28, 2024
lncRNA SNHG1 promotes the progression of hepatocellular carcinoma by regulating the miR-7-5p/IGF2BP2 axisXianggao Zhu, Hongfang Yu, Hong Li, et al.
Hereditas|December 28, 2024
Knockdown of IGF2BP2 overcomes cisplatin-resistance in lung cancer through downregulating Spon2 geneShilei Zhang, Ting Dou, Hong Li, et al.
Experimental Eye Research|September 5, 2024
Influence of dexamethasone-induced matrices on the TM transcriptomeKeerti Soundappan, Jingwen Cai, Hongfang Yu, et al.
Autoimmunity|January 22, 2014
Epigallocatechin-3-gallate modulates anti-oxidant defense enzyme expression in murine submandibular and pancreatic exocrine gland cells and human HSG cellsDouglas Dickinson, Scott DeRossi, Hongfang Yu, et al.
Viruses|February 24, 2024
Feasibility Study of Developing a Saline-Based Antiviral Nanoformulation Containing Lipid-Soluble EGCG: A Potential Nasal Drug to Treat Long COVIDNicolette Frank, Douglas Dickinson, William Garcia, et al.
International Journal of Clinical and Experimental Pathology|December 3, 2013
Delineation of biological and molecular mechanisms underlying the diverse anticancer activities of mycophenolic acidBoying Dun, Heng Xu, Ashok Sharma, et al.
Inflammation & Allergy Drug Targets|December 17, 2013
Epigallocatechin-3-gallate prevents autoimmune-associated down- regulation of p21 in salivary gland cells through a p53-independent pathwayDouglas Dickinson, Hongfang Yu, Seiji Ohno, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Neuroimmunology|May 28, 2025
Activation of NMDAR/Ca<sup>2+</sup>/CaKMII/ROS pathway by Brucella induced neuronal cell apoptosisMeiling Liu, Hongfang Yu, Yuzhe Wang, et al.
Pharmaceutics|June 27, 2024
Evaluation of Novel Nasal Mucoadhesive Nanoformulations Containing Lipid-Soluble EGCG for Long COVID TreatmentNicolette Frank, Douglas Dickinson, Garrison Lovett, et al.
Journal of Hazardous Materials|June 11, 2024
Using artificial intelligence to rapidly identify microplastics pollution and predict microplastics environmental behaviorsBinbin Hu, Yaodan Dai, Hai Zhou, et al.
Heliyon|March 28, 2024
lncRNA SNHG1 promotes the progression of hepatocellular carcinoma by regulating the miR-7-5p/IGF2BP2 axisXianggao Zhu, Hongfang Yu, Hong Li, et al.
Hereditas|December 28, 2024
Knockdown of IGF2BP2 overcomes cisplatin-resistance in lung cancer through downregulating Spon2 geneShilei Zhang, Ting Dou, Hong Li, et al.
Experimental Eye Research|September 5, 2024
Influence of dexamethasone-induced matrices on the TM transcriptomeKeerti Soundappan, Jingwen Cai, Hongfang Yu, et al.
Autoimmunity|January 22, 2014
Epigallocatechin-3-gallate modulates anti-oxidant defense enzyme expression in murine submandibular and pancreatic exocrine gland cells and human HSG cellsDouglas Dickinson, Scott DeRossi, Hongfang Yu, et al.
Viruses|February 24, 2024
Feasibility Study of Developing a Saline-Based Antiviral Nanoformulation Containing Lipid-Soluble EGCG: A Potential Nasal Drug to Treat Long COVIDNicolette Frank, Douglas Dickinson, William Garcia, et al.
International Journal of Clinical and Experimental Pathology|December 3, 2013
Delineation of biological and molecular mechanisms underlying the diverse anticancer activities of mycophenolic acidBoying Dun, Heng Xu, Ashok Sharma, et al.
Inflammation & Allergy Drug Targets|December 17, 2013
Epigallocatechin-3-gallate prevents autoimmune-associated down- regulation of p21 in salivary gland cells through a p53-independent pathwayDouglas Dickinson, Hongfang Yu, Seiji Ohno, et al.
Pageof 3